These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11692790)

  • 41. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of statin therapy on mortality in patients with non-ischemic dilated cardiomyopathy].
    Li X; Liu XP; Liu XH; Du X; Kang JP; Lü Q; Wang HY; Xu X; Liang C; Yan Q; Lei T; Geng LL; Liu BQ; Ma CS
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1974-7. PubMed ID: 20979862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Drug therapy of myocardial infarct in ambulatory practice].
    Duck HJ; Trenckmann H; Fleischmann JH; Neugebauer A; Schauer J
    Z Gesamte Inn Med; 1975 Apr; 30(8):311-5. PubMed ID: 51543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of patients' adherence to statins in Poland.
    Wiśniowska B; Skowron A
    Curr Med Res Opin; 2011 Jan; 27(1):99-105. PubMed ID: 21091392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experience with the prolonged use of beta-adrenergic blocking agents in the ambulatory treatment of patients with ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1980; 52(8):99-103. PubMed ID: 6114576
    [No Abstract]   [Full Text] [Related]  

  • 46. [Indicators of statin use as a model for qualitative evaluation of chronic disease management in the Local Health Unit Roma B].
    Ciaralli F; Summaria F; Mustilli M; Vasselli L; D'Urso A; Degrassi F
    Ig Sanita Pubbl; 2010; 66(4):511-24. PubMed ID: 21132042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug therapy of ischemic heart disease in ambulatory practice].
    Duck HJ; Trenckmann H; Fleischmann HJ; Neugebauer A; Schauer J
    Z Gesamte Inn Med; 1974 Nov; 29(22):932-6. PubMed ID: 4156817
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thromboelastographic control of blood coagulability during anticoagulant therapy of patients with coronary insufficiency under ambulatory conditions].
    Demin AA; Romashchov VP
    Klin Med (Mosk); 1966 Jan; 44(1):51-4. PubMed ID: 5984426
    [No Abstract]   [Full Text] [Related]  

  • 49. [The therapy of coronary heart disease. The current aspects].
    Mannebach H; Gleichmann U
    Dtsch Med Wochenschr; 1991 Aug; 116(34):1281-4. PubMed ID: 1678696
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antithrombotic therapy in ischemic heart disease].
    Lengyel M
    Orv Hetil; 1989 Dec; 130(49):2643-4. PubMed ID: 2601950
    [No Abstract]   [Full Text] [Related]  

  • 51. [Prevention of the initial forms of ischemic heart disease].
    Ianovskiĭ GV
    Vrach Delo; 1980 Apr; (4):32-4. PubMed ID: 6104382
    [No Abstract]   [Full Text] [Related]  

  • 52. [Recurrence of myocardial infarct after discontinued administration of oral anticoagulants: fatal rebound for certain risk groups?].
    Beer J; Schlup P
    Schweiz Med Wochenschr; 1986 Apr; 116(14):429-31. PubMed ID: 3961458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out.
    Goldstein LB; Amarenco P; Bogousslavsky J; Callahan AS; Hennerici MG; Welch KM; Zivin J; Sillesen H
    Cerebrovasc Dis; 2004; 18(1):1-2. PubMed ID: 15159613
    [No Abstract]   [Full Text] [Related]  

  • 54. [Coronary insufficiency: symptoms and diagnostic assessment. Causal/symptomatic therapy].
    Lüderitz B; Wagner WL; Manz M
    Verh Dtsch Ges Inn Med; 1990; 96():85-95. PubMed ID: 2092518
    [No Abstract]   [Full Text] [Related]  

  • 55. [Betablockers after myocardial infarction and chronic coronary heart disease].
    Vítovec J; Špinar J; Špinarová L
    Vnitr Lek; 2022; 68(3):178-180. PubMed ID: 36208948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Actihaemyl as adjuvant in cardiac therapy].
    Lordick H
    Munch Med Wochenschr; 1970 Feb; 112(7):298-300. PubMed ID: 5537795
    [No Abstract]   [Full Text] [Related]  

  • 57. [Intravenous proscillaridin A in cardiotonic therapy of the senile heart].
    Massoni G
    G Gerontol; 1968 Sep; 16(9):975-8. PubMed ID: 5754030
    [No Abstract]   [Full Text] [Related]  

  • 58. The relevance of comorbidities for heart failure treatment in primary care: A European survey.
    Sturm HB; Haaijer-Ruskamp FM; Veeger NJ; Baljé-Volkers CP; Swedberg K; van Gilst WH
    Eur J Heart Fail; 2006 Jan; 8(1):31-7. PubMed ID: 16084761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statins in the prevention of heart failure after myocardial infarction.
    Glassberg H
    Curr Heart Fail Rep; 2009 Dec; 6(4):215-9. PubMed ID: 19948089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cardiotonic effect of Cd 412 (Peruvosid) on normal humans and subjects with cardiac insufficiency].
    Rivara Ruiz G; Dejo Bustios G; Alvarez Molteni R
    Rev Esp Cardiol; 1971; 24(2):191-9. PubMed ID: 4944701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.